Teleflex (NYSE:TFX) Shares Cross Above 200-Day Moving Average – What’s Next?

Shares of Teleflex Incorporated (NYSE:TFX) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $119.67 and traded as high as $131.64. Teleflex shares last traded at $129.5690, with a volume of 602,441 shares.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on TFX. Wells Fargo & Company increased their price objective on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a research report on Saturday. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $140.00 to $160.00 in a research note on Monday, June 8th. Truist Financial restated a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a research note on Friday, May 8th. Four research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $146.00.

Teleflex Trading Up 1.4%

The company’s 50 day moving average price is $130.03 and its 200 day moving average price is $119.67. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The firm has a market cap of $5.74 billion, a PE ratio of -5.68, a price-to-earnings-growth ratio of 0.95 and a beta of 0.82.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter in the previous year, the business posted $1.44 earnings per share. The business’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, analysts forecast that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be paid a $0.34 dividend. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s payout ratio is -5.96%.

Institutional Trading of Teleflex

A number of large investors have recently modified their holdings of the stock. Banque Cantonale Vaudoise raised its stake in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares in the last quarter. V Square Quantitative Management LLC acquired a new position in Teleflex during the 4th quarter worth $37,000. UMB Bank n.a. increased its holdings in Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 113 shares during the period. Sound Income Strategies LLC purchased a new stake in Teleflex during the 4th quarter worth about $45,000. Finally, Kestra Advisory Services LLC acquired a new stake in Teleflex in the 4th quarter valued at about $45,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.